Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease.
- Resource Type
- Article
- Source
- Journal of Crohn's & Colitis; May2017, Vol. 11 Issue 5, p593-602, 10p, 4 Graphs
- Subject
- Language
- ISSN
- 18739946